This report contains market size and forecasts of Biosimilar Testing and Development Services in Global, including the following market information:
Global Biosimilar Testing and Development Services Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Biosimilar Testing and Development Services market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biosimilar Testing and Development Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biosimilar Testing and Development Services Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Biosimilar Testing and Development Services Market Segment Percentages, By Type, 2020 (%)
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays
China Biosimilar Testing and Development Services Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Biosimilar Testing and Development Services Market Segment Percentages, By Application, 2020 (%)
PK assay
Tiered Immunogenicity testing
NAb assays
Global Biosimilar Testing and Development Services Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Biosimilar Testing and Development Services Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Biosimilar Testing and Development Services Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Biosimilar Testing and Development Services Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services
Sigma-Aldrich
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Biosimilar Testing and Development Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilar Testing and Development Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilar Testing and Development Services Overall Market Size
2.1 Global Biosimilar Testing and Development Services Market Size: 2021 VS 2027
2.2 Global Biosimilar Testing and Development Services Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biosimilar Testing and Development Services Players in Global Market
3.2 Top Global Biosimilar Testing and Development Services Companies Ranked by Revenue
3.3 Global Biosimilar Testing and Development Services Revenue by Companies
3.4 Top 3 and Top 5 Biosimilar Testing and Development Services Companies in Global Market, by Revenue in 2020
3.5 Global Companies Biosimilar Testing and Development Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biosimilar Testing and Development Services Players in Global Market
3.6.1 List of Global Tier 1 Biosimilar Testing and Development Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Biosimilar Testing and Development Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Biosimilar Testing and Development Services Market Size Markets, 2021 & 2027
4.1.2 Effector Binding
4.1.3 ELISA
4.1.4 Kinetic Binding Assays
4.1.5 ADCC & CDC Cell-Based Assays
4.2 By Type - Global Biosimilar Testing and Development Services Revenue & Forecasts
4.2.1 By Type - Global Biosimilar Testing and Development Services Revenue, 2016-2021
4.2.2 By Type - Global Biosimilar Testing and Development Services Revenue, 2022-2027
4.2.3 By Type - Global Biosimilar Testing and Development Services Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biosimilar Testing and Development Services Market Size, 2021 & 2027
5.1.2 PK assay
5.1.3 Tiered Immunogenicity testing
5.1.4 NAb assays
5.2 By Application - Global Biosimilar Testing and Development Services Revenue & Forecasts
5.2.1 By Application - Global Biosimilar Testing and Development Services Revenue, 2016-2021
5.2.2 By Application - Global Biosimilar Testing and Development Services Revenue, 2022-2027
5.2.3 By Application - Global Biosimilar Testing and Development Services Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Biosimilar Testing and Development Services Market Size, 2021 & 2027
6.2 By Region - Global Biosimilar Testing and Development Services Revenue & Forecasts
6.2.1 By Region - Global Biosimilar Testing and Development Services Revenue, 2016-2021
6.2.2 By Region - Global Biosimilar Testing and Development Services Revenue, 2022-2027
6.2.3 By Region - Global Biosimilar Testing and Development Services Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Biosimilar Testing and Development Services Revenue, 2016-2027
6.3.2 US Biosimilar Testing and Development Services Market Size, 2016-2027
6.3.3 Canada Biosimilar Testing and Development Services Market Size, 2016-2027
6.3.4 Mexico Biosimilar Testing and Development Services Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Biosimilar Testing and Development Services Revenue, 2016-2027
6.4.2 Germany Biosimilar Testing and Development Services Market Size, 2016-2027
6.4.3 France Biosimilar Testing and Development Services Market Size, 2016-2027
6.4.4 U.K. Biosimilar Testing and Development Services Market Size, 2016-2027
6.4.5 Italy Biosimilar Testing and Development Services Market Size, 2016-2027
6.4.6 Russia Biosimilar Testing and Development Services Market Size, 2016-2027
6.4.7 Nordic Countries Biosimilar Testing and Development Services Market Size, 2016-2027
6.4.8 Benelux Biosimilar Testing and Development Services Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Biosimilar Testing and Development Services Revenue, 2016-2027
6.5.2 China Biosimilar Testing and Development Services Market Size, 2016-2027
6.5.3 Japan Biosimilar Testing and Development Services Market Size, 2016-2027
6.5.4 South Korea Biosimilar Testing and Development Services Market Size, 2016-2027
6.5.5 Southeast Asia Biosimilar Testing and Development Services Market Size, 2016-2027
6.5.6 India Biosimilar Testing and Development Services Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Biosimilar Testing and Development Services Revenue, 2016-2027
6.6.2 Brazil Biosimilar Testing and Development Services Market Size, 2016-2027
6.6.3 Argentina Biosimilar Testing and Development Services Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biosimilar Testing and Development Services Revenue, 2016-2027
6.7.2 Turkey Biosimilar Testing and Development Services Market Size, 2016-2027
6.7.3 Israel Biosimilar Testing and Development Services Market Size, 2016-2027
6.7.4 Saudi Arabia Biosimilar Testing and Development Services Market Size, 2016-2027
6.7.5 UAE Biosimilar Testing and Development Services Market Size, 2016-2027
7 Players Profiles
7.1 Eurofins Scientific
7.1.1 Eurofins Scientific Corporate Summary
7.1.2 Eurofins Scientific Business Overview
7.1.3 Eurofins Scientific Biosimilar Testing and Development Services Major Product Offerings
7.1.4 Eurofins Scientific Biosimilar Testing and Development Services Revenue in Global (2016-2021)
7.1.5 Eurofins Scientific Key News
7.2 SGS
7.2.1 SGS Corporate Summary
7.2.2 SGS Business Overview
7.2.3 SGS Biosimilar Testing and Development Services Major Product Offerings
7.2.4 SGS Biosimilar Testing and Development Services Revenue in Global (2016-2021)
7.2.5 SGS Key News
7.3 Charles River Laboratories
7.3.1 Charles River Laboratories Corporate Summary
7.3.2 Charles River Laboratories Business Overview
7.3.3 Charles River Laboratories Biosimilar Testing and Development Services Major Product Offerings
7.3.4 Charles River Laboratories Biosimilar Testing and Development Services Revenue in Global (2016-2021)
7.3.5 Charles River Laboratories Key News
7.4 Pharmaceutical Product Development
7.4.1 Pharmaceutical Product Development Corporate Summary
7.4.2 Pharmaceutical Product Development Business Overview
7.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Major Product Offerings
7.4.4 Pharmaceutical Product Development Biosimilar Testing and Development Services Revenue in Global (2016-2021)
7.4.5 Pharmaceutical Product Development Key News
7.5 Exova
7.5.1 Exova Corporate Summary
7.5.2 Exova Business Overview
7.5.3 Exova Biosimilar Testing and Development Services Major Product Offerings
7.5.4 Exova Biosimilar Testing and Development Services Revenue in Global (2016-2021)
7.5.5 Exova Key News
7.6 Source BioScience
7.6.1 Source BioScience Corporate Summary
7.6.2 Source BioScience Business Overview
7.6.3 Source BioScience Biosimilar Testing and Development Services Major Product Offerings
7.6.4 Source BioScience Biosimilar Testing and Development Services Revenue in Global (2016-2021)
7.6.5 Source BioScience Key News
7.7 Intertek Group
7.7.1 Intertek Group Corporate Summary
7.7.2 Intertek Group Business Overview
7.7.3 Intertek Group Biosimilar Testing and Development Services Major Product Offerings
7.4.4 Intertek Group Biosimilar Testing and Development Services Revenue in Global (2016-2021)
7.7.5 Intertek Group Key News
7.8 Medistri
7.8.1 Medistri Corporate Summary
7.8.2 Medistri Business Overview
7.8.3 Medistri Biosimilar Testing and Development Services Major Product Offerings
7.8.4 Medistri Biosimilar Testing and Development Services Revenue in Global (2016-2021)
7.8.5 Medistri Key News
7.9 Pace Analytical Services
7.9.1 Pace Analytical Services Corporate Summary
7.9.2 Pace Analytical Services Business Overview
7.9.3 Pace Analytical Services Biosimilar Testing and Development Services Major Product Offerings
7.9.4 Pace Analytical Services Biosimilar Testing and Development Services Revenue in Global (2016-2021)
7.9.5 Pace Analytical Services Key News
7.10 Sigma-Aldrich
7.10.1 Sigma-Aldrich Corporate Summary
7.10.2 Sigma-Aldrich Business Overview
7.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Major Product Offerings
7.10.4 Sigma-Aldrich Biosimilar Testing and Development Services Revenue in Global (2016-2021)
7.10.5 Sigma-Aldrich Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Biosimilar Testing and Development Services Market Opportunities & Trends in Global Market
Table 2. Biosimilar Testing and Development Services Market Drivers in Global Market
Table 3. Biosimilar Testing and Development Services Market Restraints in Global Market
Table 4. Key Players of Biosimilar Testing and Development Services in Global Market
Table 5. Top Biosimilar Testing and Development Services Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Biosimilar Testing and Development Services Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Biosimilar Testing and Development Services Revenue Share by Companies, 2016-2021
Table 8. Global Companies Biosimilar Testing and Development Services Product Type
Table 9. List of Global Tier 1 Biosimilar Testing and Development Services Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biosimilar Testing and Development Services Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type